Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 46 citing articles:

The Emerging Roles of RNA Modifications in Glioblastoma
Zhen Dong, Hongjuan Cui
Cancers (2020) Vol. 12, Iss. 3, pp. 736-736
Open Access | Times Cited: 106
Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance
Homa Fatma, S. Maurya, Hifzur R. Siddique
Seminars in Cancer Biology (2020) Vol. 83, pp. 166-176
Closed Access | Times Cited: 96
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer
Rajita Vatapalli, Vinay Sagar, Yara Rodríguez, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 85
Drug resistance in colorectal cancer: An epigenetic overview
Maochao Luo, Xingyue Yang, Hai‐Ning Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188623-188623
Open Access | Times Cited: 67
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Yan Yi, Shenglei Ge
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 40
The Chromatin Response to Double-Strand DNA Breaks and Their Repair
Radoslav Aleksandrov, Rossitsa Hristova, Stoyno Stoynov, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1853-1853
Open Access | Times Cited: 59
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Kelly E. Leon, Raquel Buj, Elizabeth Lesko, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 8
Open Access | Times Cited: 51
Histone Methyltransferase DOT1L as a Promising Epigenetic Target for Treatment of Solid Tumors
Elena Alexandrova, Annamaria Salvati, Giovanni Pecoraro, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 33
Histone methyltransferase DOT1L controls state‐specific identity during B cell differentiation
Muhammad Assad Aslam, Mir Farshid Alemdehy, Eliza Mari Kwesi‐Maliepaard, et al.
EMBO Reports (2021) Vol. 22, Iss. 2
Open Access | Times Cited: 37
Research progress and applications of epigenetic biomarkers in cancer
Jianjun Gao, Wujiang Shi, Jiangang Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Chemical biology and pharmacology of histone lysine methylation inhibitors
Samir H. Barghout, Raquel A. C. Machado, Dalia Baršytė-Lovejoy
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 6, pp. 194840-194840
Closed Access | Times Cited: 21
Gain-of-function mutations in the catalytic domain of DOT1L promote lung cancer malignant phenotypes via the MAPK/ERK signaling pathway
J. Zhang, Ting Yang, Mei Han, et al.
Science Advances (2023) Vol. 9, Iss. 22
Open Access | Times Cited: 9
C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, et al.
Current Cancer Drug Targets (2020) Vol. 21, Iss. 1, pp. 2-20
Closed Access | Times Cited: 24
Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667/MicroRNA-138-5p/Cyclin E1 Axis in Gastric Cancer
Lin Li, Zhen Dong, Pengfei Shi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 24
Tubeimoside I Inhibits Cell Proliferation and Induces a Partly Disrupted and Cytoprotective Autophagy Through Rapidly Hyperactivation of MEK1/2-ERK1/2 Cascade via Promoting PTP1B in Melanoma
Juan Du, Zhen Dong, Li Tan, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 24
Significant position of C-myc in colorectal cancer: a promising therapeutic target
Li Tan, Dong Peng, Yong Cheng
Clinical & Translational Oncology (2022) Vol. 24, Iss. 12, pp. 2295-2304
Closed Access | Times Cited: 14
Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis
Suresh Chava, Suresh Bugide, Yvonne J. K. Edwards, et al.
Oncogenesis (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 19
Primitive Erythropoiesis in the Mouse is Independent of DOT1L Methyltransferase Activity
Carrie Malcom, Anamika Ratri, Joanna Piasecka‐Srader, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 10
Histone methyltransferase DOT1L mediates the TGF-β1/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction
Fei Li, Lei Li, Jiacheng Zhang, et al.
Human Cell (2021) Vol. 35, Iss. 1, pp. 98-110
Closed Access | Times Cited: 13
Epigenetic Research in Stem Cell Bioengineering—Anti-Cancer Therapy, Regenerative and Reconstructive Medicine in Human Clinical Trials
Claudia Dompé, Krzysztof Janowicz, Greg Hutchings, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1016-1016
Open Access | Times Cited: 14
Targeting the Histone Methyltransferase Disruptor of Telomeric Silencing 1-Like Restricts Avian Leukosis Virus Subgroup J Replication by Restoring the Innate Immune Response in Chicken Macrophages
Shihao Chen, Dedong Wang, Yinyin Liu, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 14
Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells
Juncheng Guo, Yijun Yang, Min Guo, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 10-11, pp. 1136-1149
Closed Access | Times Cited: 13
Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy
Fatemeh Amjadi‐Moheb, Alireza Paniri, Haleh Akhavan‐Niaki
Cancer Research (2021) Vol. 81, Iss. 8, pp. 1925-1936
Open Access | Times Cited: 11
Dot1l Aggravates Keratitis Induced by Herpes Simplex Virus Type 1 in Mice via p38 MAPK‐Mediated Oxidative Stress
Shanshan Wan, Yiwen Zhou, Qiong Huang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 11
DOT1L promotes cell proliferation and invasion by epigenetically regulating STAT5B in renal cell carcinoma.
Yanguang Hou, Shiyu Huang, Jiachen Liu, et al.
PubMed (2023) Vol. 13, Iss. 1, pp. 276-292
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top